SE435177B - Nya halogenderivat av 2-isopropylamino-pyrimidin och forfarande for framstellning derav - Google Patents
Nya halogenderivat av 2-isopropylamino-pyrimidin och forfarande for framstellning deravInfo
- Publication number
- SE435177B SE435177B SE8003241A SE8003241A SE435177B SE 435177 B SE435177 B SE 435177B SE 8003241 A SE8003241 A SE 8003241A SE 8003241 A SE8003241 A SE 8003241A SE 435177 B SE435177 B SE 435177B
- Authority
- SE
- Sweden
- Prior art keywords
- isopropylamino
- pyrimidine
- preparing
- fluorine
- procedures
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 3
- 229910052736 halogen Inorganic materials 0.000 title claims 2
- -1 HALOGEN DERIVATIVES OF 2-ISOPROPYLAMINO-PYRIMIDINE Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims description 15
- NROKBHXJSPEDAR-UHFFFAOYSA-M potassium fluoride Chemical compound [F-].[K+] NROKBHXJSPEDAR-UHFFFAOYSA-M 0.000 claims description 6
- 235000003270 potassium fluoride Nutrition 0.000 claims description 3
- 239000011698 potassium fluoride Substances 0.000 claims description 3
- ZJQAKBVJJMKLEX-UHFFFAOYSA-N 5-bromo-n-propan-2-ylpyrimidin-2-amine Chemical group CC(C)NC1=NC=C(Br)C=N1 ZJQAKBVJJMKLEX-UHFFFAOYSA-N 0.000 claims description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims 6
- 229910052731 fluorine Inorganic materials 0.000 claims 4
- 239000011737 fluorine Substances 0.000 claims 4
- 125000001153 fluoro group Chemical group F* 0.000 claims 4
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims 3
- 229910052801 chlorine Inorganic materials 0.000 claims 3
- 239000000460 chlorine Chemical group 0.000 claims 3
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical group ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 claims 2
- FTCYIGBVOHNHCD-UHFFFAOYSA-N isaxonine Chemical compound CC(C)NC1=NC=CC=N1 FTCYIGBVOHNHCD-UHFFFAOYSA-N 0.000 claims 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims 1
- 125000001309 chloro group Chemical group Cl* 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 201000001119 neuropathy Diseases 0.000 claims 1
- 230000007823 neuropathy Effects 0.000 claims 1
- 208000033808 peripheral neuropathy Diseases 0.000 claims 1
- 239000011591 potassium Substances 0.000 claims 1
- 229910052700 potassium Inorganic materials 0.000 claims 1
- 239000002243 precursor Substances 0.000 claims 1
- 229960002317 succinimide Drugs 0.000 claims 1
- 239000000203 mixture Substances 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 4
- 241000700159 Rattus Species 0.000 description 4
- 238000007912 intraperitoneal administration Methods 0.000 description 4
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 4
- 210000003497 sciatic nerve Anatomy 0.000 description 3
- JRNVZBWKYDBUCA-UHFFFAOYSA-N N-chlorosuccinimide Chemical compound ClN1C(=O)CCC1=O JRNVZBWKYDBUCA-UHFFFAOYSA-N 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000000921 elemental analysis Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 229910052697 platinum Inorganic materials 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- XBTFODSSIVKQTO-UHFFFAOYSA-N 5-fluoro-n-propan-2-ylpyrimidin-2-amine Chemical compound CC(C)NC1=NC=C(F)C=N1 XBTFODSSIVKQTO-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- VCUFZILGIRCDQQ-KRWDZBQOSA-N N-[[(5S)-2-oxo-3-(2-oxo-3H-1,3-benzoxazol-6-yl)-1,3-oxazolidin-5-yl]methyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C1O[C@H](CN1C1=CC2=C(NC(O2)=O)C=C1)CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F VCUFZILGIRCDQQ-KRWDZBQOSA-N 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000010626 work up procedure Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB7916918 | 1979-05-15 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SE8003241L SE8003241L (sv) | 1980-11-16 |
| SE435177B true SE435177B (sv) | 1984-09-10 |
Family
ID=10505180
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE8003241A SE435177B (sv) | 1979-05-15 | 1980-04-29 | Nya halogenderivat av 2-isopropylamino-pyrimidin och forfarande for framstellning derav |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US4267181A (en:Method) |
| JP (1) | JPS55151571A (en:Method) |
| AR (1) | AR222872A1 (en:Method) |
| AT (1) | AT375074B (en:Method) |
| AU (1) | AU529581B2 (en:Method) |
| BE (1) | BE882836A (en:Method) |
| CA (1) | CA1132562A (en:Method) |
| CH (1) | CH645103A5 (en:Method) |
| DE (1) | DE3016549C2 (en:Method) |
| DK (1) | DK183980A (en:Method) |
| EG (1) | EG14260A (en:Method) |
| ES (1) | ES491004A0 (en:Method) |
| FI (1) | FI68045C (en:Method) |
| FR (2) | FR2456521A1 (en:Method) |
| HK (1) | HK55483A (en:Method) |
| IE (1) | IE49708B1 (en:Method) |
| IN (1) | IN154370B (en:Method) |
| IT (1) | IT1148798B (en:Method) |
| LU (1) | LU82379A1 (en:Method) |
| MA (1) | MA18825A1 (en:Method) |
| MX (1) | MX6295E (en:Method) |
| MY (1) | MY8400201A (en:Method) |
| NL (1) | NL8002421A (en:Method) |
| NO (1) | NO154057C (en:Method) |
| NZ (1) | NZ193533A (en:Method) |
| OA (1) | OA06526A (en:Method) |
| PT (1) | PT71162A (en:Method) |
| SE (1) | SE435177B (en:Method) |
| SG (1) | SG22483G (en:Method) |
| ZA (1) | ZA802375B (en:Method) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE894517A (fr) * | 1981-10-16 | 1983-01-17 | Sod Conseils Rech Applic | Nouveau derive de l'isopropylamino pyrimidine, sa preparation et composition therapeutiques a base de ses composes |
| US4605655A (en) * | 1984-03-06 | 1986-08-12 | Bristol-Myers Company | Antipsychotic 1-fluorophenylbutyl-4-(2-pyrimidinyl)piperazine derivatives |
| US4868161A (en) * | 1984-06-29 | 1989-09-19 | City Of Hope | Method for promoting nerve regeneration |
| US5264435A (en) * | 1988-12-29 | 1993-11-23 | Mitsui Petrochemical Industries, Ltd. | Pyrimidines and their pharmaceutical acceptable salts, and their use as medicines |
| HU206337B (en) * | 1988-12-29 | 1992-10-28 | Mitsui Petrochemical Ind | Process for producing pyrimidine derivatives and pharmaceutical compositions |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2436360A (en) * | 1948-02-17 | Preparation of z-amino-s-chloro | ||
| US2609372A (en) * | 1950-05-05 | 1952-09-02 | Sharp & Dohme Inc | Halogenation of 2-aminopyrimidines |
| US3984414A (en) * | 1971-10-09 | 1976-10-05 | Societe D'etudes De Produits Chimiques | Dichloroacetate salt of 2-isopropylamino pyrimidine |
| BE788648A (fr) * | 1971-10-09 | 1973-01-02 | Soc D Etudes Prod Chimique | Derives de l'isopropylamino pyrimidine, leur preparation leur composition et leur utilisation therapeutique |
| GB1525995A (en) * | 1976-02-18 | 1978-09-27 | Soc D Etudes Prod Chimique | Aminopyrimidine salt |
-
1980
- 1980-04-17 BE BE0/200269A patent/BE882836A/fr not_active IP Right Cessation
- 1980-04-18 CH CH301680A patent/CH645103A5/fr not_active IP Right Cessation
- 1980-04-21 ZA ZA00802375A patent/ZA802375B/xx unknown
- 1980-04-22 MA MA19020A patent/MA18825A1/fr unknown
- 1980-04-22 LU LU82379A patent/LU82379A1/fr unknown
- 1980-04-22 IN IN289/DEL/80A patent/IN154370B/en unknown
- 1980-04-24 IT IT21641/80A patent/IT1148798B/it active
- 1980-04-24 AU AU57790/80A patent/AU529581B2/en not_active Ceased
- 1980-04-24 AT AT0221480A patent/AT375074B/de active
- 1980-04-24 FI FI801330A patent/FI68045C/fi not_active IP Right Cessation
- 1980-04-25 MX MX808778U patent/MX6295E/es unknown
- 1980-04-25 NL NL8002421A patent/NL8002421A/nl not_active Application Discontinuation
- 1980-04-28 US US06/144,761 patent/US4267181A/en not_active Expired - Lifetime
- 1980-04-28 JP JP5557680A patent/JPS55151571A/ja active Granted
- 1980-04-28 NO NO801236A patent/NO154057C/no unknown
- 1980-04-28 AR AR280827A patent/AR222872A1/es active
- 1980-04-28 IE IE862/80A patent/IE49708B1/en unknown
- 1980-04-28 NZ NZ193533A patent/NZ193533A/xx unknown
- 1980-04-29 SE SE8003241A patent/SE435177B/sv not_active IP Right Cessation
- 1980-04-29 DE DE3016549A patent/DE3016549C2/de not_active Expired
- 1980-04-29 DK DK183980A patent/DK183980A/da unknown
- 1980-04-29 PT PT71162A patent/PT71162A/pt unknown
- 1980-04-29 ES ES491004A patent/ES491004A0/es active Granted
- 1980-04-29 EG EG259/80A patent/EG14260A/xx active
- 1980-04-30 OA OA57102A patent/OA06526A/xx unknown
- 1980-04-30 FR FR8009730A patent/FR2456521A1/fr active Granted
- 1980-04-30 CA CA350,989A patent/CA1132562A/en not_active Expired
- 1980-04-30 FR FR8009731A patent/FR2456734A1/fr active Granted
-
1983
- 1983-04-28 SG SG224/83A patent/SG22483G/en unknown
- 1983-11-17 HK HK554/83A patent/HK55483A/xx unknown
-
1984
- 1984-12-30 MY MY201/84A patent/MY8400201A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69110254T2 (de) | Hydroxychinolonderivate. | |
| KR101793777B1 (ko) | 만성 폐쇄성 폐 질환의 급성 악화의 치료에서의 피라졸 유도체의 용도 | |
| DE69429147T2 (de) | Benzamidderivate | |
| SE502923C2 (sv) | Användning av en polyprenylförening för framställning av protylaktiskt/terapeutiskt medel för humana och animala sjukdomar beroende på bristfälligt immunförsvar | |
| US4073895A (en) | Isopropylamino pyrimidine orthophosphate | |
| JPS6126996B2 (en:Method) | ||
| DE1949813B2 (de) | 3-(4-PyrWyl)-4-(2-hydroxyphenyl)-5-alkyl-pyrazole | |
| CN1034922A (zh) | 新四氢吡啶衍生物制备方法 | |
| FI68045C (fi) | Foerfarande foer framstaellning av terapeutiskt verkande 2-isopropylamino-5-fluor-pyrimidin | |
| US3560619A (en) | Aminoquinazolines and quinazolones in treatment of coccidiosis | |
| CN111925318A (zh) | 一个烟醇醚衍生物的马来酸盐及其晶型和应用 | |
| RU2208014C2 (ru) | ПРОИЗВОДНЫЕ 1,3-ДИОКСОЛ/4,5-h//2,3/БЕНЗОДИАЗЕПИНА, ЯВЛЯЮЩИЕСЯ ИНГИБИТОРАМИ AMPA/КАИНАТНОГО РЕЦЕПТОРА, СПОСОБ ИХ ПОЛУЧЕНИЯ, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ НА ИХ ОСНОВЕ, СПОСОБ ЛЕЧЕНИЯ | |
| JPS6116272B2 (en:Method) | ||
| HU187922B (en) | Process for preparing 3-/n,n-dimethyl-carbamoyl/-pyrazolo/1,5-a/-pyridine | |
| US4393081A (en) | Methyl 3-acetamido-2-(5-methoxy-indol-3-yl) propanoate and hypotensive use thereof | |
| SE440651B (sv) | Sett att framstella piperidyl-indol-derivat och farmaceutiska kompositioner innehallande vissa av dessa foreningar | |
| JP2520620B2 (ja) | 発癌プロモ−タ−抑制剤 | |
| RU2665037C2 (ru) | Изопропил N-[{ [(1R)-2-(6-амино-9H-пурин-9-ил)-1-метилэтокси]метил} (1,3-бензотиазол-6-ил-окси)фосфорил]-L-аланинат фумарат в качестве противовирусного препарата - пролекарства Тенофовира | |
| SE446865B (sv) | Nya derivat av 1,3-bensoxazin-2,4-dion, forfarande for framstellning derav samt farmaceutiska kompositioner | |
| HU206625B (en) | Process for producing pharmaceutical composition containing pharmaceutically active organosilane derivatives | |
| DE3239719T1 (de) | Uracil-Derivate, Verfahren zu ihrer Herstellung und dieselben enthaltende pharmazeutische Zusammensetzungen | |
| KR840001038B1 (ko) | 이소프로필 아미노 피리미딘의 신규 할로게노 유도체의 제조방법 | |
| JPS61210092A (ja) | ジヒドロピリジン−５−ホスホン酸ジアミド誘導体 | |
| JPS6312843B2 (en:Method) | ||
| KR101621742B1 (ko) | 위장 질환 치료용 바이사이클릭 락톤 화합물 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NUG | Patent has lapsed |
Ref document number: 8003241-0 Effective date: 19910117 Format of ref document f/p: F |